The U.S. Food and Drug Administration plans to enhance its testing for heavy metals in infant formula and reassess the nutrients required in these products, as announced by the agency and the U.S. Department of Health and Human Services on Tuesday.
HHS Secretary Robert F. Kennedy Jr. emphasized the FDA's commitment to ensuring the safety and quality of infant formula for families and children who depend on it. Kennedy recently met with leaders from companies such as Abbott Laboratories, which produces Similac, and Reckitt Benckiser, the maker of Enfamil.
The FDA intends to conduct a thorough review of the nutrients in infant formula and increase testing for heavy metals and other contaminants, according to the HHS statement.
Acting FDA Commissioner Sara Brenner stated that the agency is dedicated to ensuring that caregivers have confidence in the safety and availability of infant formula, which is vital for the health and development of infants and young children.
This announcement follows a report from Consumer Reports revealing that potentially harmful chemicals were found in about half of 41 infant formula products tested, including acrylamide, arsenic, BPA, lead, and PFAS. The other products showed low or no concerning chemical levels.
Brian Ronholm, director of food policy at Consumer Reports, expressed hope that the FDA will provide sufficient resources and staffing to implement the plan effectively.
In 2022, families across the U.S. experienced significant baby formula shortages after FDA inspections linked bacteria at Abbott's Sturgis, Michigan plant to two infant deaths, leading to the plant's temporary closure and a reduction in supply.
Approximately 20% of newborns in the U.S. begin their lives on formula, which is essential for their early nutrition.